Bunn F, Roberts I, Tasker R, Akpa E
Centre for Research in Primary and Community Care (CRIPACC), University of Hertfordshire, College Lane, Hatfield, Hertfordshire, UK, AL10 9AB.
Cochrane Database Syst Rev. 2004;2004(3):CD002045. doi: 10.1002/14651858.CD002045.pub2.
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume replacement may also have important disadvantages.
To determine whether hypertonic crystalloid decreases mortality in patients with hypovolaemia.
We searched MEDLINE, EMBASE, The Cochrane Controlled Trials Register and the specialised register of the Cochrane Injuries Group. We checked reference lists of all articles identified and searched the National Research Register.
Randomised trials comparing hypertonic to isotonic and near isotonic crystalloid in patients with trauma, burns or undergoing surgery.
Two authors independently extracted the data and assessed the quality of the trials.
Fourteen trials with a total of 956 participants are included in the meta-analysis. The pooled relative risk (RR) for death in trauma patients was 0.84 (95% confidence interval [CI] 0.69-1.04); in patients with burns 1.49 (95% CI 0.56-3.95); and in patients undergoing surgery 0.51 (95% CI 0.09, 2.73). In the one trial that gave data on disability using the Glasgow outcome scale, the relative risk for a poor outcome was 1.00 (95% CI 0.82, 1.22).
REVIEWERS' CONCLUSIONS: This review does not give us enough data to be able to say whether hypertonic crystalloid is better than isotonic and near isotonic crystalloid for the resuscitation of patients with trauma, burns, or those undergoing surgery. However, the confidence intervals are wide and do not exclude clinically significant differences. Further trials which clearly state the type and amount of fluid used and that are large enough to detect a clinically important difference are needed.
高渗溶液被认为具有更强的扩充血容量能力,从而升高血压,并且可以在短时间内以小容量输注的方式给药。另一方面,使用高渗溶液进行容量补充也可能存在重要的缺点。
确定高渗晶体液是否能降低低血容量患者的死亡率。
我们检索了MEDLINE、EMBASE、Cochrane对照试验注册库以及Cochrane损伤组的专门注册库。我们检查了所有已识别文章的参考文献列表,并检索了国家研究注册库。
比较高渗晶体液与等渗和近等渗晶体液用于创伤、烧伤或手术患者的随机试验。
两位作者独立提取数据并评估试验质量。
荟萃分析纳入了14项试验,共956名参与者。创伤患者死亡的合并相对风险(RR)为0.84(95%置信区间[CI]0.69 - 1.04);烧伤患者为1.49(95%CI 0.56 - 3.95);手术患者为0.51(95%CI 0.09, 2.73)。在一项使用格拉斯哥预后量表给出残疾数据的试验中,不良预后的相对风险为1.00(95%CI 0.82, 1.22)。
本综述没有给我们足够的数据来确定高渗晶体液在创伤、烧伤患者或手术患者复苏方面是否优于等渗和近等渗晶体液。然而,置信区间很宽,并不排除具有临床意义的差异。需要进一步的试验,明确说明所用液体的类型和数量,并且规模要足够大以检测出具有临床重要意义的差异。